Reply to: Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia

Pediatr Blood Cancer. 2023 Jan;70(1):e29833. doi: 10.1002/pbc.29833. Epub 2022 Jul 7.

Giacomo Gotti^{1

2

3}, Kristen Stevenson⁴, Samantha Kay-Green^{1

2}, Traci M Blonquist⁴, Jason S Mantagos⁵, Lewis B Silverman^{1

2}, Andrew E Place^{1

2}

¹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
² Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
³ Pediatric Hematology-Oncology, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
⁴ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
⁵ Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, USA.

No abstract available

Publication types